20.78CHF-3.35%Mkt Cap: 935.36M $P/E: 346.331d ago
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two se…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap935.36M $
Enterprise Value907.63M $
Revenue (TTM)166.70M $
Gross Profit147.69M $
Net Income (TTM)2.91M $
Revenue/Share4.337 USD
Last Price20.78 CHF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees178
CountryCH
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)346.33
P/E (Forward)43.20
PEG—
EV/EBITDA69.03
EV/Revenue5.44
P/S5.61
P/B11.91
EPS (TTM)0.06
EPS (Forward)0.48
52W Range
17.6919% of range34.20
52W High34.20 CHF
52W Low17.69 CHF
Profitability
Gross Margin88.60%
Oper. Margin6.59%
EBITDA Margin7.89%
Profit Margin1.75%
ROE3.02%
ROA1.91%
Growth
Revenue Growth66.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-519.29K $
CapEx (TTM)2.78M $
FCF Margin-2.69%
FCF Yield-0.48%
Net Debt-20.98M $
Net Debt/EBITDA-1.60
Balance Sheet
Debt/Equity0.02
Current Ratio1.96
Quick Ratio1.42
Book Value/Sh1.745 CHF
Cash/Share0.5050 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CHF
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateOct 8, 2020
Splits
Last Split1:100
Split DateJun 23, 2016
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)34.27 CHF
Upside (mean)+64.9%
Target Range32.00 CHF – 38.00 CHF
CHF32.00+64.9% to meanCHF38.00
# Analysts3
Ownership
Shares Out.39.44M
Float28.94M
Insiders28.90%
Institutions22.10%
Technical
SMA 5020.08 (+3.5%)
SMA 20025.12 (-17.3%)
Beta0.74
S&P 52W Chg19.63%
Avg Vol (30d)175.33K
Avg Vol (10d)156.30K
Technical Indicators
RSI (14)54.9
MACD0.3284
MACD Signal0.0549
MACD Hist.+0.2736
BB Upper22.16 CHF
BB Middle19.56 CHF
BB Lower16.97 CHF
BB Width26.50%
ATR (14)0.9967 CHF
Vol Ratio (20d)0.37x